NewsLocalCyprus re-evaluating chloroquine and hydroxychloroquine for Covid-19 patients

Cyprus re-evaluating chloroquine and hydroxychloroquine for Covid-19 patients

The Health Ministry has advised doctors to curtail the use of chloroquine and hydroxychloroquine on some COVID-19 patients amid renewed concerns that the drugs could trigger heart problems and put lives at risk.

The ministry urged doctors to be “particularly vigilant” and to even stop administering the two substances to COVID-19 patients with pre-existing heart conditions.

An advisory body of medical experts is re-evaluating the use of the drugs and may revise its directives, it said.

The announcement came after the World Health Organization said it would temporarily drop hydroxychloroquine from its global study into experimental COVID-19 treatments.

A paper published last week in the Lancet showed people taking hydroxychloroquine were at higher risk of death and heart problems than those that were not.

 

Top Stories

Taste